Socolate 2% (Ophthalmic Solution)

Product title

• Socolate Cromoglycate 2% Eye Drops

Categories

• Eye Drops
• Ophthalmic Products
• Allergy Relief
• Eye Care

Description

• Sodium Cromoglycate 2% sterile Eye Drops used for the prophylaxis and symptomatic treatment of allergic ocular disorders.

Indication

• Prophylaxis and symptomatic treatment of allergic ocular disorders
• Relief of itching, tearing, redness, and discharge

Pharmacology

• Inhibition of release of chemical mediators from sensitized mast cells
• Local effect on the mucous of the eye
• Minimal systemic absorption

Dosage and administration

• 1-2 drops in each eye 4-6 times daily

Interaction

• No known drug interactions

Contraindications

• Hypersensitivity to the drug or any of the ingredients

Side effects

• Transient ocular stinging or burning upon instillation

Pregnancy and lactation

• Insufficient evidence for safety in pregnancy
• Caution in nursing women

Precautions and warnings

• Contains benzalkonium chloride
• Avoid wearing soft contact lenses during treatment

Overdose effects

• Overdose unlikely; symptomatic treatment recommended for accidental ingestion

Therapeutic class

• Mast Cell Stabiliser
• Ophthalmic Non-Steroid drugs

Storage conditions

• Protect from direct sunlight
• Store at a temperature less than 30˚C
• Discard unused solution after 4 weeks

Dosage form

• Sterile Eye Drops

Age group

• Adults
• Children over 4 years of age or older

Relief duration

• Symptomatic relief within a few days

Absorption rate

• Approximately 0.03% systemically absorbed

Allergic reaction modulation

• Modulation of allergic response to antigen-antibody interactions

Formulation type

• Ophthalmic solution

Treatment duration

• Up to 6 weeks for optimum symptomatic relief in some patients

Fertility impact

• No evidence of impaired fertility in animal studies

Animal studies

• Produced adverse effects on the fetus only in high parenteral doses

Distribution in milk

• Unknown if distributed into milk in humans

Storage duration after opening

• Discard 4 weeks after opening the cap of the bottle

Temperature sensitivity

• Store at a temperature less than 30˚C

Light sensitive

• Protect from direct sunlight

Contact lens

• Avoid wearing soft contact lenses during treatment

Safety use caution

• Use with caution in pregnancy and lactation

Ocular administration

• Ophthalmic administration

Symptomatic improvement

• Once improvement is established, continue therapy for as long as needed

Ocular mucous effect

• Local effect on the mucous of the eye

Phosphorylation ability

• Capable of rapid phosphorylation of mast cell protein

Allergic mediator prevention

• Prevents release of mediators of type-I allergic reactions

Inflammatory mediator prevention

• Prevents release of toxic or inflammatory mediators

Long allergic reaction suppression

• Inhibits Type-III (late allergic, Arthus) reactions

Therapeutic effect dependency

• Therapeutic effects depend on regular administration

Caution in nursing

• Use with caution in nursing women

Optimum relief time

• Up to 6 weeks for optimum symptomatic relief in some patients

Substance absence

• Does not inhibit the binding of IgE to mast cells

Immune response suppression

• Suppresses the release of substances in response to antigen-antibody reaction

Related Brands